CCDA Selective Supplement

Not available outside of the UK & Ireland.

Analysis Note

Typical composition (per vial): Amphotericin B 5.0 mg; Cefoperazone 16.0 mg. Growth promotion test in accordance with ISO 11133. Supplement tested with base Art. 1.00070.Growth - Campylobacter coli ATCC 43478 (WDCM 00004): good - Campylobacter jejuni ATCC 33291 (WDCM 00005): good - Campylobacter jejuni ATCC 29428 (WDCM 00156): good - Staphylococcus aureus ATCC 25923 (WDCM 00034): no growth - Escherichia coli ATCC 25922 (WDCM 00013): inhibited growth - Escherichia coli ATCC 8739 (WDCM 00012): inhibited growthIncubation: 44 hrs. 41.5 °C with Anaercult C. E.coli and Staph.aur. aerobic. Strains tested with three-loop-streak.

Application

CCDA Selective Supplement is an additive used during the preparation of Campylobacter Blood Free Selective Agar for the enrichment of Campylobacter from foods.

General description

CCDA Selective Supplement is a mixture of two antibiotics (Amphotericin B & Cefoperazone) in lyophilized form. Amphotericin B largely reduces the growth of yeasts and molds, while Cefoperazone especially inhibits the growth of Enterobacteriaceae.

Linkage

Replaces: 1.00071

Packaging

10 vial in Fibre case